Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane Boumendil

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|February 6, 2019
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMTGiorgia Battipaglia, Ariane Boumendil, Myriam Labopin, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2019
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationOlle Ringdén, Ariane Boumendil, Myriam Labopin, et al.
Journal of Hematology & Oncology|July 6, 2019
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMTSimona Piemontese, Ariane Boumendil, Myriam Labopin, et al.
Bone Marrow Transplantation|February 8, 2024
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donorAnnalisa Paviglianiti, Maud Ngoya, Marta Peña, et al.
Leukemia & Lymphoma|July 14, 2020
Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMTCarmen Martínez, Ariane Boumendil, Joanna Romejko-Jarosinska, et al.
Blood|January 31, 2013
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMTEsa Jantunen, Ariane Boumendil, Herve Finel, et al.
Bone Marrow Transplantation|January 17, 2018
Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working PartyStephen P Robinson, Ariane Boumendil, Herve Finel, et al.
Plos One|October 27, 2022
Consent is a confounding factor in a prospective observational study of critically ill elderly patientsHans Flaatten, Bertrand Guidet, Christian Jung, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|February 6, 2019
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMTGiorgia Battipaglia, Ariane Boumendil, Myriam Labopin, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2019
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationOlle Ringdén, Ariane Boumendil, Myriam Labopin, et al.
Journal of Hematology & Oncology|July 6, 2019
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMTSimona Piemontese, Ariane Boumendil, Myriam Labopin, et al.
Bone Marrow Transplantation|February 8, 2024
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donorAnnalisa Paviglianiti, Maud Ngoya, Marta Peña, et al.
Leukemia & Lymphoma|July 14, 2020
Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMTCarmen Martínez, Ariane Boumendil, Joanna Romejko-Jarosinska, et al.
Blood|January 31, 2013
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMTEsa Jantunen, Ariane Boumendil, Herve Finel, et al.
Bone Marrow Transplantation|January 17, 2018
Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working PartyStephen P Robinson, Ariane Boumendil, Herve Finel, et al.
Plos One|October 27, 2022
Consent is a confounding factor in a prospective observational study of critically ill elderly patientsHans Flaatten, Bertrand Guidet, Christian Jung, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Pageof 11